Stocks · Health care · Pharmaceutical Preparations

Annexon, Inc.

ANNX Clue Score37

United States Fiscal year ends December CIK 0001528115 Results filed 12 Aug 2026

Add to watchlist

What the insiders did No buying or selling

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Muneer A Satter

Director

—

—

—

10,342,134

6.92%

$39.61M

+39.6%

Douglas Love

President and CEO

—

—

—

390,476

0.2614%

$1.50M

+17.8%

Ted Yednock

EVP & Chief Innovation Officer

—

—

—

184,807

0.1237%

$707.81K

+58.9%

Michael Overdorf

EVP & Chief Business Officer

—

—

—

182,625

0.1223%

$699.45K

+30.8%

Dean Richard Artis

EVP & Chief Scientific Officer

—

—

—

180,093

0.1206%

$689.76K

+34.1%

Jennifer Lew

EVP & Chief Financial Officer

—

—

—

170,700

0.1143%

$653.78K

+29.9%

Jamie Dananberg

Chief Medical Officer

—

—

—

123,582

0.0827%

$473.32K

+47.2%

William H. Carson

Director

—

—

—

78,405

0.0525%

$300.29K

+250.0%

Jung Choi

Director

—

—

—

33,000

0.0221%

$126.39K

—